Early redemption of convertible bonds (incl. overseas CBs)

What happened

Korea Pharma / Early acquisition of convertible bonds (including overseas convertible bonds) after issuance / (2026.08.28) Early acquisition of convertible bonds (including overseas convertible bonds) after issuance Early acquisition of convertible bonds (including overseas convertible bonds) after issuance Convertible bonds (overseas convertible bonds), Series 4

1. Matters concerning the bonds acquired before maturity Type of bond: Series 4 registered non-coupon unsecured private-placement convertible bonds Issue date: 2023-11-28 Issuance method: Domestic issuance (private placement) Conversion price per share (KRW): 21,862 Maturity date: 2028-11-28

2. Bond acquisition amount (currency unit): 5,000,000,000 KRW: South-Korean Won - Face value (electronically registered amount) of bonds acquired (currency unit): 5,000,000,000 KRW: South-Korean Won - Reference exchange rate: - - Acquisition date: 2026-08-28

3. Remaining face value (electronically registered amount) of bonds after acquisition (currency unit): - KRW: South-Korean Won

4. Reason for acquisition before maturity and future handling method 1. Reason for acquisition: Acquisition due to exercise of the early-redemption put option 2. Future handling method: Cancellation of the bond registered with the Korea Securities Depository

5. Source of acquisition funds: Own funds

6. Bond acquisition method: Over-the-counter purchase

7. Other matters for investors' reference - The "acquisition date" above is the payment date of the acquisition amount.

Related disclosures 2023-11-24 Decision to issue convertible bonds (Series 4) 2026-05-28 Early acquisition of convertible bonds (including overseas convertible bonds) after issuance